Please contact us for more information or to learn if you are eligible to participate.
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread to other places in the body (metastatic).
Edgar Lopez Pacheco
National Cancer Institute (NCI)
Type of Trial